Use of rebamipide gastroprotector agent in clinical practice-Reference-Cited by-同舟云学术

Use of rebamipide gastroprotector agent in clinical practice

Published:2022-07-01 Issue:7 Volume: Page:52-58
ISSN:
Container-title:Glavvrač (Chief Medical Officer)
language:
Short-container-title:Chief Medical Officer

Author:

Frolova A. A., ,Shindina T. S.,Maslovskiy L. V.,Maksimov M. L.,Aleksandrova E. B.,Kropova O. E., , , , ,

Abstract

Recent studies have indicated that rebamipide is a drug with a pleiotropic effect, covering the upper and lower gastrointestinal tract and also extending beyond it. Rebamipide has prospects for use in endocrinology (in the model of diabetes mellitus, the drug showed hypoglycemic and antioxidant functions, which helped alleviate the symptoms of diabetic nephropathy); an anti-atherosclerotic effect of rebamipide has been shown; in rheumatology, its ability to reduce inflammation in the joints has been revealed; it is used in ophthalmology in dry eye syndrome, lagophthalmos, corneal erosion, etc. (due to its ability to increase corneal and conjunctival mucin-like substances), and can be applied in other areas as well. This article discusses the possibilities of using rebamipide in gastroenterology, depending on the various parts of the gastrointestinal tract.

Publisher

PANORAMA Publishing House

Reference9 articles.

1. 1. Maksimov, M. L. Klinicheskaia farmakologiia i ratsionalnaia farmakoterapiia dlia praktikuiushchikh vrachei [Clinical pharmacology and rational pharmacotherapy for practitioners]: manual / M. L. Maksimov, R. A. Bont¬sevich, I. S. Burashnikova [et al.]; ed. prof. M. L. Maksimov. - Kazan: Publishing House «MedDoc», 2021. - 948 p. ISBN 978 5 6045764 9 6 (In Russ.)

2. 2. Naito Y., Yoshikawa T. Rebamipide: a gastrointestinal protective drug with pleiotropic activities // Expert Rev. Gastroenterol. Hepatol. 2010.4 (3). P.261-70

3. 3. Kleine A., Kluge S., Peskar B. M. Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats //Dig Dis Sci 1993. 38 (8). P.1441-9.

4. 4. Ivashkin V. T., Trukhmanov A. S., Gonik M. I. Primenenie rebamipida v lechenii gastroezofagealnoi refliuksnoi bolezni [The use of rebamipide in the treatment of gastroesophageal reflux disease]. Terapevticheskii arkhiv [Therapeutic Archive]. 2020.92 (4). P. 98-104. (In Russ.)

5. 5. Takemoto T, Namiki M, Yachi A, Masamune O, Ishikawa M, Goto Y, Kimura K, Itoh S, Matsuo Y, Kobayashi M, Oka H, Tsuchiya M, Kurokawa K, Yokoyama I, Okabe H, Miwa T, Kohli Y, Nakazawa S, Takeuchi T, Uchino H, Miyake T, Kawai K, Kamada T, Kobayashi K, Ohshiba S, Tsuji T, Kajiyama G, Shimada Y, Okazaki Y, Kishi S, Nawata H, Tan¬ikawa K, Hayakawa H, Hashimoto S: Effect of rebamipide (OPC-12759) on gastric ulcer healing multicenter, double-blind, cetraxate controlled clinical study.// Rinsho Seijin-byo 1989.19. Р.1265-1291.